Investing News NetworkYour trusted source for investing success

Videos
Companies
Press Releases
Top Stocks
Top Resource Stocks
Top Tech Stocks
Top Life Science Stocks
Private Placements
Trending
Trending Articles

Could the Silver Price Really Hit $100 per Ounce? (Updated 2024)

How Would a New BRICS Currency Affect the US Dollar? (Updated 2024)

Uranium Stocks: 5 Biggest Companies in 2024

7 Biggest Lithium-mining Companies in 2024

Top 10 Oil-producing Countries (Updated 2024)

Hydrogen Stocks: 9 Biggest Companies in 2024

10 Largest Producers of Gold by Country (Updated 2024)

Top 10 Gold-mining Companies (Updated 2024)

What Was the Highest Price for Gold? (Updated 2024)

Trending Press Releases

Saga Metals Lists on TSX-V

Heritage Mining Announces Partnership with Altitude Capital Consultants Inc. and Non-Brokered Private Placement

Outstanding Drill Results Confirm High Grade Uranium Mineralisation at the Ashburton Project

Pinnacle Silver and Gold Provides Corporate Update and Grants Incentive Stock Options

SAGA Metals Completes IPO with Focus on Uranium Exploration and Rio Tinto Partnership

World Class Copper Potential Increased at Yataga Copper Project – Georgetown, QLD

More Press Releases
Trending Companies

Saga Metals

SAGA:CA

Element79 Gold Corp

ELEM:CC

Forum Energy Metals

FMC:CA

Black Swan Graphene

SWAN:CC
More Companies
Trending Reports

2024 Copper Outlook Report

2024 Gold Outlook Report

2024 Lithium Market Outlook

Silver Price Forecast - What Happened And Where Do We Go From Here?

More Outlook Reports
Resource
Resource
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Tech
Tech
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Life Science
Life Science
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Gold Price
Silver Price
Copper Price
Oil Price
Uranium
Artificial Intelligence
loader

Metacrine Inc.

NASDAQ:MTCR
Press Releases

Metacrine Inc is a clinical-stage biopharmaceutical company focused on discovering and developing differentiated therapies for patients with liver and gastrointestinal diseases. Its program targets the farnesoid X receptor, or FXR, which is central to modulating liver and GI diseases. Its FXR product candidates include MET409 and MET642.

Interactive Chart

×